ArticleBJPsych open2023
Prevalence and economic burden of dementia in the Arab world.
Article in BJPsych open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Epidemiological and economic burden of dementia in the Middle East and North African region.Journal of Alzheimer's disease : JAD · 2025Pooled it
- Ethical dilemmas in the care of patients with Alzheimer's disease and related dementias unable to give informed consent: positioning Lebanon within the Global North-South context.BMC medical ethics · 2025Pooled it
- A narrative review of challenges faced by informal caregivers of people with dementia in the Middle East and North Africa.Frontiers in medicine · 2025Pooled it
- Uncovering the extent of dementia prevalence in Iran: a comprehensive systematic review and meta-analysis.BMC public health · 2024Pooled it
- The 2024 Lebanon conflict: a multidimensional assessment of syndemic impacts on public health and sustainable development goals.Internal and emergency medicine · 2026Review
- Epidemiology, risk determinants, and research trends of dementia in Saudi Arabia: A systematic review.Journal of Alzheimer's disease : JAD · 2026Review
- Elevated MicroRNA-146a in Alzheimer's Disease and Its Diagnostic Potential.Molecular neurobiology · 2026Article
- Midlife Vascular and Lifestyle Determinants of Late-Life Cognitive Decline and Dementia: A Life-Course Prevention Framework with a Gulf (GCC) Perspective.Life (Basel, Switzerland) · 2026Review
- Effects of Traditional and Technology-Based Exercise Interventions on Cognitive Function in Older Adults: A Systematic Review and Meta-Analysis.Journal of Intelligence · 2026Review
- Dementia in the Middle East and North Africa: an integrative narrative review of epidemiology, risk structure, and health system implications.Journal of global health · 2026Review
- Article
- Dementia care in the United Arab Emirates: an environmental scan of services, policy, workforce, and caregiving contexts.BMC health services research · 2026Article
- Cognitive decline, and quality of life: evidence from community-dwelling older adults in the United Arab Emirates.Frontiers in aging · 2026Article
- Why dementia is often not diagnosed by subtype: care pathways and imaging access in the United Arab Emirates.Frontiers in psychiatry · 2026Article
- Knowledge, awareness, and practice of undergraduate medical students on Alzheimer's disease and dementia in Oman.Journal of education and health promotion · 2026Article
- Expert Guidance on Cognitive Impairment in Alzheimer's Disease: A Practical Seven-Step Approach from the United Arab Emirates.Neurology and therapy · 2025Article
- Global incidence trends and projections of Alzheimer disease and other dementias: an age-period-cohort analysis 2021.Journal of global health · 2025Article
- Overview and Regional Context of Alzheimer's Disease in the Middle East and North Africa Region.Cureus · 2025Review
- Assessing the determinants and association of cognitive memory performance with blood folate and cobalamin levels in Qatar's healthy aging population.Qatar medical journal · 2025Article
- Assessing the knowledge of Alzheimer's disease among interns from different healthcare professions in Jeddah, Saudi Arabia: a cross-sectional study.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe growing prevalence of dementia is a global concern, especially in the Arab world, where updated economic impact data are scarce. Understanding its prevalence and cost is crucial for effective policies and support systems.
aimsTo estimate dementia prevalence and cost in Arab countries for 2021.
methodUnited Nations population data and dementia prevalence estimates were used to calculate total cases. Direct costs were based on gross domestic product (GDP) per capita (purchasing power parity) and income classification. Indirect caregiver support costs were estimated using average monthly wages and two distinct scenarios.
resultsThe highest dementia prevalence among those aged more than 60 years was in Lebanon (4.88%), Tunisia (4.43%) and Algeria (4.19%). The total direct cost in the Arab region was $8.18 billion for those over 50 years old. Indirect costs ranged from $2.25 billion (best case) to $5.67 billion (worst case), with a mean value of $3.98 billion. Total dementia care costs (direct and indirect) under the mean scenario for the entire Arab world amounted to $12.17 billion, with costs as a percentage of GDP ranging from 0.05% (Sudan) to 0.44% (Lebanon).
conclusionsThis study highlights dementia as a growing public health issue in the Arab world, with 1 329 729 individuals affected in 2021 and total costs between $10.43 billion and $13.90 billion. The findings emphasise the urgent need for investment in research and specialised services for older adults, particularly those with dementia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.